We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Xceleron and JCL Bioassay Announce Partnership in Early Clinical Investigations

News   Mar 19, 2013

 
Xceleron and JCL Bioassay Announce Partnership in Early Clinical Investigations
 
 
 

RELATED ARTICLES

Study Identifies Effective Ketamine Doses for Treatment-Resistant Depression

News

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

READ MORE

Probiotic Bacillus Eliminates Harmful Staphylococcus Bacteria

News

A “good” bacterium commonly found in probiotic digestive supplements helps eliminate Staphylococcus aureus, cause of serious antibiotic-resistant infections.

READ MORE

Paralysis from Rare Disorder: Stem Cell Therapy Trial Brings Hope

News

A clinical trial is planned to see if a single injection of progenitor cells can help repair spinal cords inflamed by transverse myelitis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE